Navigation Links
PAREXEL International Reports Second Quarter Fiscal Year 2013 Results
Date:1/29/2013

d," "could," "should,"  "targets," and similar expressions are also intended to identify forward-looking statements.  The forward-looking statements in this release involve a number of risks and uncertainties.  The Company's actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release.  Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent and anticipated restructurings; the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business, manage growth and costs, and attract and retain employees; the Company's ability to complete additional acquisitions, and to integrate newly acquired businesses "including the recent acquisition of Liquent, Inc.", or enter into new lines of business; the impact on the Company's business of government regulation of the drug,  medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations and other international economic, political, and other risks.
Such factors and others are discussed more fully in the section entitled "Risk Factors" of the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2012 as filed with the SEC on November 8, 2012, which "Risk Factors" discussion is incorporated by reference in this press release.  The Company specifically disclaims any obligation to update these forward-looking s
'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
2. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
3. Parexel Invites Public To Listen To Live Webcast Of Its Investor Day May 31, 2012
4. PAREXEL Chairman And CEO To Ring The Bell At The NASDAQ Stock Market Opening
5. PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day
6. PAREXEL International To Present At NASDAQ OMX Investor Conference
7. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2012 Earnings Release and Conference Call
8. PAREXEL And Korea Drug Development Fund Announce Alliance To Accelerate Global Drug Development And Commercialization
9. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
10. PAREXEL Strengthens Outcomes Research Capabilities To Help Biopharma Meet Commercialization Goals
11. PAREXEL International to Present at Robert Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Aug. 19, 2014  Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) ... , Sanofi and Regeneron will host an IR Thematic ... Tuesday, September 2, 2014 , Baird 2014 Healthcare ... 3, 2014 , Citi,s 9 th Annual ... September 4, 2014 , Morgan Stanley Global Healthcare ...
(Date:8/19/2014)... Colo. , Aug. 19, 2014 ... Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE), ... rd Annual Meeting of the American Academy ... Acute Care Surgery in Philadelphia, Pennsylvania ... 2014.  The presentation will report results from a ...
(Date:8/19/2014)... August 19, 2014 According to ... (Neurosurgical Navigation Systems, ENT Navigation Systems and Orthopedic ... Trends and Forecast, 2014 - 2020", the global surgical ... in 2013 and is expected to grow at a ... an estimated value of USD 295.5 million in 2020. ...
Breaking Medicine Technology:Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 2Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 3Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 2Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 3Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 4Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 5Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 6Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 7Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 8Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 9
... China , July 9 /PRNewswire-Asia-FirstCall/ -- ... or the "Company"), a,developer, manufacturer and distributor of ... announced,that on July 8, 2010 , the ... Red Star Forest Bureau of Heilongjiang Province ...
... ATHENS, Greece , July 9 The companies ... and translator of the Greek language version of the GeneMedRx ... the program will include hundreds of drugs used exclusively in ... Greek language graphical user interface. Both the English and Greek ...
Cached Medicine Technology:Renhuang Signs Exclusive Purchase Agreement for Siberian Ginseng 2Renhuang Signs Exclusive Purchase Agreement for Siberian Ginseng 3Renhuang Signs Exclusive Purchase Agreement for Siberian Ginseng 4Medigene Appointed Exclusive Greek Licensee for GeneMedRx Personalized Prescribing Software 2
(Date:8/19/2014)... published in this week,s JAMA highlights the ... when considering how to treat patients. Written by Robert ... and chair of pediatrics at Boston University School of ... , the editorial examines results of a study published ... example of how doctors can often over-emphasize certain types ...
(Date:8/19/2014)... Recently, UWDress.com, a professional company of women’s ... plus size formal evening dresses . Additionally, the firm ... outfits. At the moment, all of them can be ordered ... will be valid until August 27, 2014. , The ... top designers believe that women of all shapes can be ...
(Date:8/19/2014)... Horizon Blue Cross Blue Shield of New Jersey ... again teaming up during The Barclays at The Ridgewood ... Challenge, and Horizon BCBSNJ will be getting spectators into the ... their own. , Horizon BCBSNJ, the official health care sponsor ... donation to the New Jersey Golf Foundation, an organization that ...
(Date:8/19/2014)... ME (PRWEB) August 19, 2014 Drews Dental ... J. Drews, D.D.S., to vice president of the Maine Dental ... MDA for three years, Dr. Drews has now been sworn ... forward to serving his term as vice president and being ... as well as the First District Caucus in 2015. He ...
(Date:8/19/2014)... smoke during their stay and could use this time as ... smoke-free after returning home. Now a study published in ... program that increased the proportion of hospitalized smokers who successfully ... The system used interactive voice response technology automated telephone ... months after smokers left the hospital. , "Most ...
Breaking Medicine News(10 mins):Health News:Review of clinical treatment of bronchiolitis in infants reveals over-reliance on one test 2Health News:Cheap Plus Size Formal Evening Dresses Announced By UWDress.com 2Health News:Horizon Blue Cross Blue Shield of New Jersey Pairs up with PGA TOUR Pro Morgan Hoffmann for Walking Challenge During The Barclays for Charity and to Promote Good Health 2Health News:Horizon Blue Cross Blue Shield of New Jersey Pairs up with PGA TOUR Pro Morgan Hoffmann for Walking Challenge During The Barclays for Charity and to Promote Good Health 3Health News:Horizon Blue Cross Blue Shield of New Jersey Pairs up with PGA TOUR Pro Morgan Hoffmann for Walking Challenge During The Barclays for Charity and to Promote Good Health 4Health News:Dr. Drews Elected VP of Maine Dental Association 2Health News:Extended support helps patients stay smoke-free after hospital discharge 2
... , , , ... the U.S. Food and Drug Administration (FDA) has approved a 3000 ... factor (recombinant). The new vial size offers greater convenience for ... , The 3000 IU vial may eliminate the need ...
... , NEW YORK, Aug. 7 President Bill ... Yancy, president of the American Heart Association and Dr. ... the Fourth Annual Healthy Schools Program Forum in New York to honor 114 ... to learn and staff to work. , , "As kids ...
... , ARDEE, Ireland, Aug. 7 /PRNewswire-Firstcall/ ... its results for the quarter ended June 30, 2009. Revenue in ... over the prior year quarter. The primary drivers of the increase ... and ESTRACE Cream which were partially offset by net sales declines ...
... , LOS ANGELES, Aug. 7 "August marks ... comments Susan, mother of five and teacher who recalls living with ... next you,d have thought Satan walked through the door." , ... *(Photo Caption/Cutline: Mother with drug-free daughter, a Narconon graduate.) , ...
... ... RN, MBA, CMRP, as vice president for consulting. , ... St. Louis, MO (Vocus) -- Navvis & ... consulting. Cleveland brings to the firm and its clients extensive experience and expertise in ...
... Carnegie Mellon University have developed an analytical technique ... to complex disease syndromes such as diabetes, asthma ... and molecular traits. , Rather than searching one ... a particular symptom or trait, as in ...
Cached Medicine News:Health News:FDA Approves New 3000 IU Vial Size for Kogenate(R) FS, antihemophilic factor (recombinant) 2Health News:FDA Approves New 3000 IU Vial Size for Kogenate(R) FS, antihemophilic factor (recombinant) 3Health News:FDA Approves New 3000 IU Vial Size for Kogenate(R) FS, antihemophilic factor (recombinant) 4Health News:More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 2Health News:More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 3Health News:More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 4Health News:More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 5Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 2Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 3Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 4Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 5Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 6Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 7Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 8Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 9Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 10Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 11Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 12Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 13Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 14Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 15Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 16Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 17Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 18Health News:Mother & Daughter Celebrate Victory Over 'Meth' 2Health News:Cleveland Joins Navvis & Company 2Health News:Carnegie Mellon develops innovative method to detect genetic causes of complex diseases 2
This apron was designed by Pulse Medical-RCI for optimal protection. Your comfort is also a primary concern so a wide support belt and shoulder pads are standard. When properly fitted, an overlapping...
... full protection is necessary, the Two-Piece ... add to your comfort through more ... greater flexibility. The vest comes with ... hanging loops as well as an ...
Quick Release buckle apron is user friendly with large support straps crisscrossing the back allowing proper placement of the belt at your waist....
... unique velcro design apron has ... support and comfort. Shoulder pads ... flaps aid in relieving weight ... fit is attained by varying ...
Medicine Products: